Skip to Main Content

Cell-Type-Resolved Chromatin Effects of AD/PD Variants: DNA Language Model vs. ChromBPNet. We asked whether a general DNA language model can rival the specialized CNN ChromBPNet at predicting how non-coding variants affect chromatin accessibility. We fine-tuned our model, NucEL, on the same brain DNase-seq and GM12878 ATAC data and ran ChromBPNet's own endpoints. NucEL beat zero-shot ChromBPNet at accessibility classification in all four brain cell types and on GM12878 (0.967 vs 0.899), and independently reproduced ChromBPNet's variant-effect atlas (ρ=0.50; CR1 the shared top AD hit). A 1×→50× scaling curve shows the gap is data-limited, not architectural — suggesting general sequence models can match purpose-built regulatory CNNs given enough data.

Team

Placement

Participant

More from Built with Claude: Life Sciences

What I built. Lazarus is an agent that takes a dead research repository that is open, cited, and no longer runnable, and turns it back into a callable…

DoctorDean project preview

Diffuse midline glioma is a paediatric brainstem cancer that is almost uniformly fatal: about ninety percent of children die within two years, and the first…

Faith Ogundimu project preview

Hippocampus AI is the memory and reasoning engine for scientific discovery. Every experiment generates valuable knowledge, but that knowledge becomes…

Disruptors project preview

I used Claude to train a protein language model that can generate an extremophilic version of any enzyme, maintaining its function, while allowing it to…

Jaymin project preview

Many primates are sexually dichromatic — males and females are different colors. I wanted to know how that trait is built genetically, and how it evolved…

www.loom.com/…

About Trialign is a patient-facing clinical trial matcher for oncology. A patient pastes a clinical note, uploads a record, or connects their EHR via SMART on…

Trialign project preview